DEFINITIVE PROXY STATEMENT

Company

Xenetic Biosciences, Inc.

Filed

November 13, 2023

Period of Report

December 6, 2023

Accession Number

0001683168-23-007992

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →